Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules.

In contrast to the molecular etiology of autonomously functioning thyroid nodules, the molecular cause of cold thyroid nodules (CTNs), their benign, functional inactive counterparts, are so far largely unknown. Because of the partially dedifferentiated phenotype of CTNs, alterations in signaling cascades that favor proliferation, but not differentiation, are likely candidates for tumor induction and progression. The importance of RAS mutations for the development of benign nodules with follicular histology is still in question. However, differentially expressed genes in the context of their signaling cascades could define aberrant signaling in CTNs. Therefore, we investigated gene expression in 22 CTNs and their normal surrounding tissue using Affymetrix GeneChips. Most prominently, data analysis revealed an increased expression of cell cycle-associated genes and a special relevance of protein kinase C signaling, whereas no evidence of RAS-MAPK signaling in CTNs was found. Moreover, we determined 31 differentially regulated genes in CTNs, including several histone mRNAs. Taken together, these results explain recent findings showing an increased proliferation in CTNs and draw attention to protein kinase C signaling, but away from RAS-MAPK signaling, as being involved in the etiology of CTNs.

[1]  R. Paschke,et al.  Cold thyroid nodules show a marked increase in proliferation markers. , 2003, Thyroid : official journal of the American Thyroid Association.

[2]  L. Reis,et al.  Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. , 2003, Cancer letters.

[3]  Steven C. Lawlor,et al.  GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.

[4]  J. Fagin,et al.  Clonal composition of benign and malignant human thyroid tumors. , 1990, The Journal of clinical investigation.

[5]  R. Paschke,et al.  Ras mutations are rare in solitary cold and toxic thyroid nodules , 2001, Clinical endocrinology.

[6]  W. R. Bishop,et al.  Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[7]  J. Köhrle,et al.  Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. , 1994, The Journal of clinical endocrinology and metabolism.

[8]  M. Fey,et al.  Clonal Analysis of Human Tumors with M27,6, a Highly Informative Polymorphic X Chromosomal Probe , 2013 .

[9]  J. Massagué,et al.  Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage , 2002, Nature.

[10]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[11]  R. Paschke,et al.  BRAF Mutations Are Not an Alternative Explanation for the Molecular Etiology of ras -Mutation Negative Cold Thyroid Nodules , 2004 .

[12]  S. Asa,et al.  Clonality of thyroid nodules in sporadic goiter. , 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[13]  A. V. Van Herle,et al.  Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA R0 82 W-1) in vitro. , 1990, The Journal of clinical endocrinology and metabolism.

[14]  Charis Eng,et al.  Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. , 2003, Cancer research.

[15]  S. S. Young,et al.  Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .

[16]  L. Bachrach,et al.  Phorbol esters stimulate growth and inhibit differentiation in cultured thyroid cells. , 1985, Endocrinology.

[17]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Takasu,et al.  Tumour promoter 12-O-tetradecanoylphorbol 13-acetate and epidermal growth factor stimulate proliferation and inhibit differentiation of porcine thyroid cells in primary culture. , 1987, The Journal of endocrinology.

[19]  A. Belfiore,et al.  The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine‐deficient area , 1987, Cancer.

[20]  J. Köhrle,et al.  Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[21]  R. Paschke,et al.  Gene expression analysis reveals evidence for inactivation of the TGF-β signaling cascade in autonomously functioning thyroid nodules , 2004, Oncogene.

[22]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo* , 2003, Journal of Biological Chemistry.

[23]  Z. Kraiem,et al.  Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles. , 1995, Endocrinology.

[24]  J. Richardson EFFECTS 1 , 2022 .

[25]  M. Stratton,et al.  Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. , 2002, Cancer research.

[26]  A. Allgeier,et al.  Mutation analysis of the Epac--Rap1 signaling pathway in cold thyroid follicular adenomas. , 2001, European journal of endocrinology.

[27]  J. Parma,et al.  The thyrotropin receptor and the regulation of thyrocyte function and growth. , 1992, Endocrine reviews.

[28]  D. Segev,et al.  Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia. , 1998, The Journal of clinical endocrinology and metabolism.

[29]  D. Wynford‐Thomas,et al.  RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation , 2000, Oncogene.

[30]  J. Klose,et al.  Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. , 1999, Methods in molecular biology.

[31]  Guoying Liu,et al.  NetAffx: Affymetrix probesets and annotations , 2003, Nucleic Acids Res..

[32]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[33]  C. Esapa,et al.  Prevalence of Ras mutations in thyroid neoplasia , 1999, Clinical endocrinology.

[34]  B. Haye,et al.  Tetradecanoyl phorbol-13-acetate counteracts the responsiveness of cultured thyroid cells to thyrotropin. , 1985, Biochemical pharmacology.

[35]  S. Kropf,et al.  Multivariate tests based on left-spherically distributed linear scores , 1998 .

[36]  M. Donovan,et al.  The cellular retinoic acid binding proteins , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  M. Gleave,et al.  Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. , 2000, Endocrinology.

[38]  J. Dumont,et al.  Stimulation of cell proliferation and inhibition of differentiation expression by tumor-promoting phorbol esters in dog thyroid cells in primary culture. , 1986, Cancer research.

[39]  I. Roninson Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. , 2002, Cancer letters.

[40]  Yuri E Nikiforov,et al.  High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. , 2003, Cancer research.

[41]  R. Paschke,et al.  Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I- symporter. , 1999, The Journal of clinical endocrinology and metabolism.

[42]  R. Paschke,et al.  Complementary DNA expression array analysis suggests a lower expression of signal transduction proteins and receptors in cold and hot thyroid nodules. , 2001, The Journal of clinical endocrinology and metabolism.

[43]  R. Duronio,et al.  Histone mRNA expression: multiple levels of cell cycle regulation and important developmental consequences. , 2002, Current opinion in cell biology.

[44]  S. Mohan,et al.  Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. , 1999, Endocrinology.

[45]  M. Stratton,et al.  Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. , 1997, American journal of human genetics.

[46]  R. Paschke,et al.  Increased thyroid epithelial cell proliferation in toxic thyroid nodules. , 1999, Thyroid : official journal of the American Thyroid Association.

[47]  C Eng,et al.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Berridge Inositol trisphosphate and calcium signalling , 1993, Nature.

[49]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[50]  P. Carayon,et al.  Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. , 2003, Endocrinology.

[51]  J. Puck,et al.  Clonal analysis of solitary follicular nodules in the thyroid. , 1990, The American journal of pathology.

[52]  R. Paschke,et al.  Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. , 2004, The Journal of clinical endocrinology and metabolism.

[53]  A. de la Chapelle,et al.  Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma , 2003, International journal of cancer.

[54]  J. Köhrle,et al.  Retinoic acid redifferentiation therapy for thyroid cancer. , 2000, Thyroid : official journal of the American Thyroid Association.